1Rattarasam C, Leelawattana R, Soonthorbpun S, et al. Regional abdominal fat distribution in lean and obese Thai type 2 diabetic women: rela tionships with insulin sensitivity and cardiovascular risk factors.Metabolism, 2003,52: 1444-1447.
2Ross R, Aru J, Freeman J, et al. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab, 2002, 282:E657-E663.
3Brochu M, Starling RD, Tchernof A, et al. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab, 2000,85: 2378-2384.
4Cnop M, Landchild M J, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartmeuts. Diabetes,2002,51:1005-1015.
5Gabriely 1, Ma XH, Yang XM, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes, 2002,51: 2951-2958.
6Bjorntor P. Metabolic difference between visceral fat and subcutaneous abdominal fat. Diabetes Metab,2000,26(Suppl 3):10-12.
7Harmelen V, Dicker A, Ryden M, et al. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes,2002,51:2029-2036.
8Pujol E, Redriguez-Cuenca S, Frontera M, et al. Gender- and site-related effects on lipolytic capacity of rat white adipose tissue. Cell Mol Life Sci, 2003,60: 1982-1989.
9Panarotto D, Poisson J, Devroede G, et al. Lipoprotein lipase steadystate mRNA levels are lower in human omental versus subcutaneous abdominal adipose tissue. Metabolism, 2000,49: 1224-1227.
10Laplante M, Sell H, MacNaul KL, et al. PPAR-gamma activatiou mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipidemia and differential adipose accretion. Diabetes, 2003,52: 291-299.
